Medication-overuse headache. Retrospective comparison of preventive treatments

Detalhes bibliográficos
Autor(a) principal: Krymchantowski,Abouch V.
Data de Publicação: 2018
Outros Autores: Krymchantowski,Ana Gabriela Ferreira, Jevoux,Carla da Cunha
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018001000668
Resumo: ABSTRACT Objectives: Medication-overuse headache is commonly seen in tertiary centers. Limited evidence is available regarding treatment. We compared the use of one or two drugs, three drugs, or four pharmacological agents for the prevention of headache. Methods: This was a retrospective analysis of 149 consecutive patients. Sudden withdrawal and pharmacological prevention with one or more drugs were carried out. Adherence and the decrease of headache frequency of more than 50% were compared after four months between the one or two, three, and four drug groups. Results: There was no difference in adherence (p > 0.6). Headache frequency reduction was shown in 23 (54.8%, one or two drugs), 33 (70%, three drugs) and 11 (55%, four drugs); p = 0.13 and p = 0.98, not significant. There was a tendency towards significance between the one or two drug takers versus the three drug and four drug takers together (p = 0.09). Conclusions: The use of more drugs was not better at improving headache. However, there is the possibility that acting simultaneously on different sites may promote broader modulation and better outcome.
id ABNEURO-1_53c0a6f086abf96d0b43c42151d05197
oai_identifier_str oai:scielo:S0004-282X2018001000668
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Medication-overuse headache. Retrospective comparison of preventive treatmentsMedication-overuseheadachemigrainetreatmentABSTRACT Objectives: Medication-overuse headache is commonly seen in tertiary centers. Limited evidence is available regarding treatment. We compared the use of one or two drugs, three drugs, or four pharmacological agents for the prevention of headache. Methods: This was a retrospective analysis of 149 consecutive patients. Sudden withdrawal and pharmacological prevention with one or more drugs were carried out. Adherence and the decrease of headache frequency of more than 50% were compared after four months between the one or two, three, and four drug groups. Results: There was no difference in adherence (p > 0.6). Headache frequency reduction was shown in 23 (54.8%, one or two drugs), 33 (70%, three drugs) and 11 (55%, four drugs); p = 0.13 and p = 0.98, not significant. There was a tendency towards significance between the one or two drug takers versus the three drug and four drug takers together (p = 0.09). Conclusions: The use of more drugs was not better at improving headache. However, there is the possibility that acting simultaneously on different sites may promote broader modulation and better outcome.Academia Brasileira de Neurologia - ABNEURO2018-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018001000668Arquivos de Neuro-Psiquiatria v.76 n.10 2018reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20180097info:eu-repo/semantics/openAccessKrymchantowski,Abouch V.Krymchantowski,Ana Gabriela FerreiraJevoux,Carla da Cunhaeng2018-10-29T00:00:00Zoai:scielo:S0004-282X2018001000668Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2018-10-29T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Medication-overuse headache. Retrospective comparison of preventive treatments
title Medication-overuse headache. Retrospective comparison of preventive treatments
spellingShingle Medication-overuse headache. Retrospective comparison of preventive treatments
Krymchantowski,Abouch V.
Medication-overuse
headache
migraine
treatment
title_short Medication-overuse headache. Retrospective comparison of preventive treatments
title_full Medication-overuse headache. Retrospective comparison of preventive treatments
title_fullStr Medication-overuse headache. Retrospective comparison of preventive treatments
title_full_unstemmed Medication-overuse headache. Retrospective comparison of preventive treatments
title_sort Medication-overuse headache. Retrospective comparison of preventive treatments
author Krymchantowski,Abouch V.
author_facet Krymchantowski,Abouch V.
Krymchantowski,Ana Gabriela Ferreira
Jevoux,Carla da Cunha
author_role author
author2 Krymchantowski,Ana Gabriela Ferreira
Jevoux,Carla da Cunha
author2_role author
author
dc.contributor.author.fl_str_mv Krymchantowski,Abouch V.
Krymchantowski,Ana Gabriela Ferreira
Jevoux,Carla da Cunha
dc.subject.por.fl_str_mv Medication-overuse
headache
migraine
treatment
topic Medication-overuse
headache
migraine
treatment
description ABSTRACT Objectives: Medication-overuse headache is commonly seen in tertiary centers. Limited evidence is available regarding treatment. We compared the use of one or two drugs, three drugs, or four pharmacological agents for the prevention of headache. Methods: This was a retrospective analysis of 149 consecutive patients. Sudden withdrawal and pharmacological prevention with one or more drugs were carried out. Adherence and the decrease of headache frequency of more than 50% were compared after four months between the one or two, three, and four drug groups. Results: There was no difference in adherence (p > 0.6). Headache frequency reduction was shown in 23 (54.8%, one or two drugs), 33 (70%, three drugs) and 11 (55%, four drugs); p = 0.13 and p = 0.98, not significant. There was a tendency towards significance between the one or two drug takers versus the three drug and four drug takers together (p = 0.09). Conclusions: The use of more drugs was not better at improving headache. However, there is the possibility that acting simultaneously on different sites may promote broader modulation and better outcome.
publishDate 2018
dc.date.none.fl_str_mv 2018-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018001000668
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018001000668
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282x20180097
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.76 n.10 2018
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212784209395712